See more : PIETRO Co., Ltd. (2818.T) Income Statement Analysis – Financial Results
Complete financial analysis of Divi’s Laboratories Limited (DIVISLAB.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Divi’s Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Prosperity International Holdings (H.K.) Limited (0803.HK) Income Statement Analysis – Financial Results
- Hanwha Life Insurance Co., Ltd. (088350.KS) Income Statement Analysis – Financial Results
- Sierra Madre Gold and Silver Ltd. (SMDRF) Income Statement Analysis – Financial Results
- Prajay Engineers Syndicate Limited (PRAENG.BO) Income Statement Analysis – Financial Results
- Atlantic Navigation Holdings (Singapore) Limited (5UL.SI) Income Statement Analysis – Financial Results
Divi's Laboratories Limited (DIVISLAB.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.divislabs.com
About Divi's Laboratories Limited
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 78.45B | 76.66B | 87.99B | 68.58B | 52.91B | 48.04B | 38.07B | 40.53B | 37.69B | 31.15B | 25.32B | 21.45B | 18.64B | 13.17B | 9.42B | 11.80B | 103.28B | 7.25B | 3.81B |
| Cost of Revenue | 32.69B | 30.54B | 29.67B | 23.24B | 21.09B | 18.25B | 15.34B | 15.34B | 15.04B | 12.13B | 9.14B | 7.99B | 7.62B | 6.03B | 3.97B | 6.25B | 5.11B | 3.67B | 2.03B |
| Gross Profit | 45.76B | 46.12B | 58.32B | 45.34B | 31.83B | 29.79B | 22.73B | 25.19B | 22.65B | 19.02B | 16.18B | 13.46B | 11.02B | 7.13B | 5.45B | 5.56B | 98.17B | 3.58B | 1.78B |
| Gross Profit Ratio | 58.33% | 60.17% | 66.28% | 66.11% | 60.15% | 62.00% | 59.71% | 62.15% | 60.09% | 61.05% | 63.90% | 62.77% | 59.14% | 54.17% | 57.88% | 47.08% | 95.05% | 49.35% | 46.74% |
| Research & Development | 790.00M | 300.50M | 202.90M | 149.70M | 111.40M | 106.00M | 101.10M | 119.50M | 309.24M | 276.62M | 253.91M | 239.99M | 188.59M | 159.81M | 112.83M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.25B | 1.25B | 1.08B | 831.40M | 746.90M | 541.10M | 905.30M | 428.10M | 378.80M | 342.03M | 295.06M | 271.84M | 166.88M | 726.63M | 745.56M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 900.00M | 1.14B | 1.27B | 1.24B | 853.60M | 730.80M | 640.20M | 674.80M | 560.36M | 519.30M | 442.20M | 512.94M | 536.29M | 51.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.06B | 2.39B | 2.35B | 2.07B | 1.60B | 1.27B | 1.55B | 1.10B | 939.15M | 861.33M | 737.26M | 784.79M | 703.16M | 778.50M | 745.56M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 103.00M | 42.40M | 26.00M | 40.50M | 17.10M | 23.10M | 22.40M | 28.35M | 6.57M | 11.41M | 3.24M | 17.34M | 3.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 11.85B | 25.85B | 22.58B | 19.18B | 15.42B | 12.68B | 11.47B | 11.55B | 9.60B | 8.63B | 6.89B | 6.06B | 4.72B | 2.65B | 2.50B | 2.19B | 1.44B | 1.38B | 724.41M |
| Cost & Expenses | 45.37B | 56.39B | 52.25B | 42.42B | 36.50B | 30.93B | 26.81B | 26.89B | 24.64B | 20.76B | 16.03B | 14.05B | 12.34B | 8.69B | 6.47B | 8.43B | 6.55B | 5.05B | 2.75B |
| Interest Income | 3.01B | 2.05B | 689.60M | 572.40M | 66.60M | 74.80M | 43.50M | 54.80M | 97.12M | 46.46M | 60.98M | 27.27M | 7.00M | 12.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 30.00M | 3.30M | 3.70M | 3.90M | 55.40M | 21.20M | 5.50M | 11.90M | 24.28M | 5.66M | 9.13M | 7.54M | 24.95M | 15.17M | 27.79M | 72.43M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.78B | 3.43B | 3.12B | 2.56B | 1.86B | 1.69B | 1.42B | 1.23B | 1.18B | 1.36B | 921.16M | 769.48M | 620.82M | 533.96M | 514.85M | 478.51M | 356.80M | 223.46M | 148.21M |
| EBITDA | 25.43B | 27.14B | 39.97B | 29.24B | 20.13B | 20.27B | 13.76B | 15.21B | 15.12B | 12.11B | 10.20B | 8.60B | 7.45B | 5.26B | 3.46B | 5.00B | 97.09B | 2.42B | 1.21B |
| EBITDA Ratio | 32.42% | 35.39% | 45.43% | 42.65% | 36.96% | 41.65% | 36.19% | 37.41% | 40.26% | 39.03% | 43.03% | 40.08% | 40.03% | 39.97% | 36.77% | 42.64% | 94.00% | 33.34% | 31.62% |
| Operating Income | 33.08B | 20.62B | 35.62B | 25.61B | 16.09B | 16.49B | 10.78B | 13.80B | 13.12B | 10.80B | 9.97B | 7.83B | 6.84B | 4.73B | 2.95B | 4.55B | 96.73B | 2.19B | 1.06B |
| Operating Income Ratio | 42.17% | 26.90% | 40.48% | 37.34% | 30.40% | 34.34% | 28.32% | 34.06% | 34.80% | 34.67% | 39.39% | 36.50% | 36.70% | 35.92% | 31.30% | 38.59% | 93.66% | 30.26% | 27.73% |
| Total Other Income/Expenses | -11.45B | -11.04B | -11.04B | -9.44B | 1.79B | 1.45B | 1.05B | 311.40M | 879.32M | 332.04M | -334.06M | -15.63M | -34.49M | -4.69M | 906.15M | -74.59M | -92.95B | -2.67M | -2.11B |
| Income Before Tax | 21.63B | 23.69B | 36.84B | 26.66B | 18.19B | 18.55B | 12.31B | 13.95B | 13.93B | 10.72B | 9.91B | 7.81B | 6.81B | 4.72B | 3.85B | 4.48B | 3.77B | 2.19B | -1.06B |
| Income Before Tax Ratio | 27.57% | 30.90% | 41.86% | 38.87% | 34.39% | 38.62% | 32.34% | 34.42% | 36.96% | 34.42% | 39.13% | 36.42% | 36.52% | 35.88% | 40.92% | 37.97% | 3.66% | 30.26% | -27.73% |
| Income Tax Expense | 5.63B | 5.45B | 7.23B | 6.82B | 4.43B | 5.02B | 3.54B | 3.35B | 2.67B | 2.21B | 2.18B | 1.79B | 1.47B | 431.05M | 449.91M | 315.87M | 299.01M | 333.80M | 361.48M |
| Net Income | 16.00B | 18.24B | 29.60B | 19.84B | 13.77B | 13.53B | 8.77B | 10.60B | 11.26B | 8.52B | 7.73B | 6.02B | 5.33B | 4.29B | 3.40B | 4.17B | 3.48B | 1.86B | 695.34M |
| Net Income Ratio | 20.40% | 23.79% | 33.64% | 28.93% | 26.02% | 28.16% | 23.03% | 26.16% | 29.87% | 27.34% | 30.54% | 28.07% | 28.61% | 32.61% | 36.14% | 35.30% | 3.37% | 25.65% | 18.25% |
| EPS | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 | 50.96 | 33.04 | 39.95 | 42.41 | 32.08 | 29.13 | 22.68 | 20.10 | 16.21 | 13.06 | 16.10 | 13.46 | 7.25 | 2.71 |
| EPS Diluted | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 | 50.96 | 33.04 | 39.95 | 42.41 | 32.08 | 29.13 | 22.68 | 20.10 | 16.20 | 13.03 | 15.94 | 13.31 | 7.16 | 2.66 |
| Weighted Avg Shares Out | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.35M | 264.82M | 260.74M | 258.86M | 258.23M | 256.45M | 256.37M |
| Weighted Avg Shares Out (Dil) | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.47M | 265.35M | 264.93M | 261.23M | 261.46M | 261.22M | 259.51M | 261.29M |
Source: https://incomestatements.info
Category: Stock Reports